Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units

[at noodls] – TORONTO, March 25, 2013 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and … more

View todays social media effects on IPCI

View the latest stocks trending across Twitter. Click to view dashboard

See who Intellipharmaceutics is hiring next, click here to view